Monoamines and their metabolites in Huntington's disease brain: evidence for decreased catechol-O-methyltransferase activity.
McGeer
E G
EG
Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, Canada.
Kremer
B
B
Hayden
M R
MR
D000368:Aged; D001921:Brain / Q000473:pathology*; D002394:Catechol O-Methyltransferase / Q000378:metabolism*; D002421:Caudate Nucleus / Q000473:pathology; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis / Q000235:genetics / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000378:metabolism*; D011699:Putamen / Q000473:pathology
D018377:Neurotransmitter Agents; D002394:Catechol O-Methyltransferase